(Q43812432)

27 November 2017

title

Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer (English)

1 reference

27 November 2017

1 reference

11

Yoshihiko Maehara

1 reference

27 November 2017

Ryota Nakanishi

1

1 reference

27 November 2017

Jun Harada

2

1 reference

27 November 2017

Munkhbold Tuul

3

1 reference

27 November 2017

Yan Zhao

4

1 reference

27 November 2017

Koji Ando

5

1 reference

27 November 2017

Hiroshi Saeki

6

1 reference

27 November 2017

Eiji Oki

7

1 reference

27 November 2017

Takefumi Ohga

8

1 reference

27 November 2017

Hiroyuki Kitao

9

1 reference

27 November 2017

Yoshihiro Kakeji

10

1 reference

27 November 2017

publication date

29 November 2012

1 reference

International Journal of Clinical Oncology

27 November 2017

published in

1 reference

27 November 2017

volume

18

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1042-1048

1 reference

Lymph node ratio is a powerful prognostic index in patients with stage III distal rectal cancer: a Japanese multicenter study

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Molecular analysis of colorectal tumors within a diverse patient cohort at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Cetuximab plus capecitabine and irinotecan compared with cetuximab plus capecitabine and oxaliplatin as first-line treatment for patients with metastatic colorectal cancer: AIO KRK-0104--a randomized trial of the German AIO CRC study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Systemic therapy for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Precise assessment of microsatellite instability using high resolution fluorescent microsatellite analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Microsatellite instability in colorectal cancer-the stable evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

KRAS mutations detected by the amplification refractory mutation system-Scorpion assays strongly correlate with therapeutic effect of cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Analyzing the Risk of Recurrence after Mastectomy for DCIS: A New Use for the USC/Van Nuys Prognostic Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Role of DNA 5-methylcytosine transferase in cell transformation by fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Transcription repression in oncogenic transformation: common targets of epigenetic repression in cells transformed by Fos, Ras or Dnmt1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Colorectal cancer epigenetics: complex simplicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

Pathology report in colon cancer: what is prognostically important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0501-X

[Clinical significance of BRAF mutations in colorectal cancer].

21 January 2018

1 reference

12 December 2020

[A case of paraneoplastic limbic encephalitis associated with malignant lymphoma presenting with a late-onset bilateral thalamic lesion].

1 reference

12 December 2020

Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up

1 reference

12 December 2020

Prevention of local recurrence by extended lymphadenectomy for rectal cancer

1 reference

12 December 2020

[Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas]

1 reference

12 December 2020

Using Predictive Biomarkers to Select Patients With Advanced Colorectal Cancer for Treatment With Epidermal Growth Factor Receptor Antibodies

1 reference

12 December 2020

Red meat intake may increase the risk of colon cancer in Japanese, a population with relatively low red meat consumption.

1 reference

12 December 2020

Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer

1 reference

12 December 2020

Exclusive KRAS mutation in microsatellite-unstable human colorectal carcinomas with sequence alterations in the DNA mismatch repair gene, MLH1

1 reference

12 December 2020

Predictive and prognostic markers in colorectal cancer

1 reference

12 December 2020

Clinicopathological characteristics of poorly differentiated adenocarcinoma of the colon and rectum

1 reference

12 December 2020

Differential gene expression signatures between colorectal cancers with and without KRAS mutations: crosstalk between the KRAS pathway and other signalling pathways

1 reference

12 December 2020

10.1007/S10147-012-0501-X

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1015190056

0 references

Fatcat ID

release_2tefyabkd5a6rnjjshhsxxzq5e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2tefyabkd5a6rnjjshhsxxzq5e

24 November 2022

mapped directly with Wikidata item

1 reference